← Back to Clinical Trials
Recruiting NCT06692569

NCT06692569 The Effect of Modified Constraint Induced Movement Therapy on Upper Extremity Function in Stroke Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06692569
Status Recruiting
Phase
Sponsor University of Jazan
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2024-11-12
Primary Completion 2025-07-13

Trial Parameters

Condition Stroke
Sponsor University of Jazan
Study Type INTERVENTIONAL
Phase N/A
Enrollment 34
Sex ALL
Min Age 45 Years
Max Age 65 Years
Start Date 2024-11-12
Completion 2025-07-13
Interventions
Conventional Physical TherapyModified Constraint Induced Movement Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of the study is to determine the effect of Modified Constraint-Induced Movement Therapy and trunk restraint contrasted with conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients. * To find out the effectiveness of conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients. * To find out the effectiveness of modified constraint induced movement therapy (mCIMT) and trunk restraint along with conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients. * To find out the effectiveness of modified constraint induced movement therapy (mCIMT) and trunk restraint combined with conventional physical therapy treatment versus conventional physical therapy treatment alone on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.

Eligibility Criteria

Inclusion Criteria: * Right or left-sided chronic hemiplegic patients. * Onset of stroke More than six months. * Age between 45 to 65 years of both genders. * Mini-Mental State Examination - Scored more than 24/30. * Modified Ashworth Scale for spasticity 1 or 1+. * Have at least 20° wrist active extension and at least 10° of metacarpophalangeal active extension of the paretic upper extremity. * Have at least grade 2/5 of muscle power on upper extremity especially in wrist extensors. * Have normal visual perception. * With no other neurological disorders. Exclusion Criteria: * Unable to follow visual and oral commands. * Unilateral neglect. * Severe cognitive, or language deficits.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology